Search
Neurocrine Biosciences Inc
NBIXAdd to Watchlist
166.800USD
-18.700-10.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.95BMarket Cap
24.90P/E TTM
NBIX Financials
See Neurocrine Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Neurocrine Biosciences Inc Earnings Date
Latest Release
Jul 30, 2026
EPS / Forecast
1.43/1.34
Revenue / Forecast
959.00M/885.80M
Period
FY2025 Earnings
Revenue(YoY)
2.86B
21.45%
EPS(YoY)
4.81
41.50%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its total revenue reached 2.86B, with a year-on-year change of 2.36B.
What are the current assets of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its current assets were 2.52B, with a year-on-year change of 46.27.
What are the total assets of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its total assets of Neurocrine Biosciences Inc were 4.63B, with a year-on-year change of 24.55.
What are the total liabilities of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its total liabilities of Neurocrine Biosciences Inc were 1.38B, with a year-on-year change of 22.09.
What is the total equity of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its total equity of Neurocrine Biosciences Inc was 3.25B, with a year-on-year change of 25.62.
What is the net operating income of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its net operating income of Neurocrine Biosciences Inc was 636.50M, with a year-on-year change of 9.18.
What is the net investment of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its net investment of Neurocrine Biosciences Inc was -264.40M, with a year-on-year change of -108.52.
What is the net financing of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its net financing of Neurocrine Biosciences Inc was -38.30M, with a year-on-year change of 92.13.
What is the Earnings Per Share (EPS) of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 4.81, with a year-on-year change of 41.50.
What is the net income of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its net income was 478.60M, with a year-on-year change of 40.23.
What is the net margin of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its net profit margin was 16.73, with a year-on-year change of 15.46.
What is the gross margin of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its gross margin was 98.18, with a year-on-year change of -0.38.
What is the Return on Equity (ROE) of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was 16.38, with a year-on-year change of 15.72.
What is the Return on Assets (ROA) of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was 11.46, with a year-on-year change of 17.05.
What is the operating profit of Neurocrine Biosciences Inc?
According to Neurocrine Biosciences Inc's FY2025 earnings report, its operating profit was 636.50M, with a year-on-year change of 9.18.